Join to access to all OVN content. Join for Free
Emotional Intelligence and the MSL: More Important than EVER
Emotional Intelligence MSL profession Sanofi company culture leadership development

Emotional Intelligence and the MSL: More Important than EVER


Share This Article


Summary

In this episode, Doug Yau from Sanofi joins Tom Caravela to delve into the critical role of emotional intelligence in the MSL profession. They explore the definition, components, and the profound impact of emotional intelligence on influence and access within the industry. Doug shares insights on how emotional intelligence can be taught and improved, emphasizing its importance in company culture, leadership, and during interviews. The discussion also covers strategies for assessing and developing these skills. The episode wraps up with reflections on the conversation and a call to action for listeners.

Doug Yau, Sr Director, Oncology MSLs at Sanofi discusses why Emotional Intelligence is more important for MSL success than ever before.

Doug shares…

👉 What Emotional Intelligence (EQ) is in his own words

👉 Why EQ is important for MSLs at the present time

👉 How to improve your emotional intelligence

👉 What companies should be offering to help employees develop EQ

👉 How does EQ play a factor in interviews

Click for Source
Emotional Intelligence, MSL profession, Sanofi, company culture, leadership development

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
MSL People Skills: Top 10 Tips for Better Engagement
Partner Avatar Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Article
“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders
Partner Avatar Tom Caravela

“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders

Podcast
The VALUE of Management Skills
Partner Avatar MSL Talk: Tom Caravela, Angela Tom

The VALUE of Management Skills

Podcast
Good vs Great: What Makes a Rock STAR MSL?
Partner Avatar MSL Talk: Tom Caravela, Sanaz Cardoza

Good vs Great: What Makes a Rock STAR MSL?

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Explore OVN